Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.

Market Cap 49.14B 7.37B 6.59B 6.09B 5.52B 10.33B 701B 10.49B 73.32B 29B 367B 27.64B 27.05B 1,160B P/E 2026 *
37.9x
P/E 2027 * 28.4x
Enterprise Value 44.76B 6.71B 6B 5.55B 5.02B 9.4B 638B 9.56B 66.78B 26.42B 334B 25.18B 24.64B 1,057B EV / Sales 2026 *
5.55x
EV / Sales 2027 * 4.6x
Free-Float
62.13%
Yield 2026 *
0.92%
Yield 2027 * 1.29%
Manager TitleAgeSince
Chief Executive Officer 70 07/10/1998
Chief Executive Officer 49 19/01/2022
President - -
Director TitleAgeSince
Director/Board Member 49 18/07/2011
Chairman 70 07/10/1998
Director/Board Member 65 18/07/2011
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 7.7B
+0.45%+1.76%+54.96%+118.11% 1,135B
+0.94%+4.20%+39.86%+75.69% 635B
+0.39%+0.46%+25.77%+97.40% 505B
+1.43%+4.56%+46.20%+66.91% 378B
-3.21%-3.66%+60.72%+35.68% 358B
-0.41%+2.23%+22.48%+48.54% 295B
+0.23%+3.28%+2.57%+21.89% 266B
+1.22%+2.81%+52.40%+63.37% 237B
+1.70%+1.60%+31.21%+102.44% 193B
Average +0.24%+1.60%+37.35%+70.00% 444.85B
Weighted average by Cap. +0.31%+1.63%+41.40%+81.03%

Financials

2026 *2027 *
Net sales 8.06B 1.21B 1.08B 1B 905M 1.69B 115B 1.72B 12.03B 4.76B 60.13B 4.54B 4.44B 190B 9.89B 1.48B 1.33B 1.23B 1.11B 2.08B 141B 2.11B 14.75B 5.84B 73.74B 5.56B 5.44B 233B
Net income 1.33B 199M 178M 165M 149M 279M 18.93B 284M 1.98B 784M 9.9B 747M 731M 31.35B 1.78B 266M 238M 220M 200M 373M 25.34B 380M 2.65B 1.05B 13.25B 1B 978M 41.96B
Net Debt -4.38B -657M -587M -544M -492M -921M -62.51B -936M -6.54B -2.59B -32.69B -2.47B -2.41B -104B -3.66B -549M -491M -454M -411M -769M -52.2B -782M -5.46B -2.16B -27.3B -2.06B -2.02B -86.45B
Logo Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories Tianjin Co Ltd is a China-based company mainly engaged in providing one-stop comprehensive services for pharmaceutical outsourcing. The Company's business includes customized research and development and production of small molecule drugs (CDMO), chemical macromolecule CDMO, clinical research services, formulation CDMO, biological macromolecule CDMO, technology output and synthetic biology. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company mainly conducts its business in domestic and foreign markets.
Employees
10,617
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Asymchem Laboratories (Tianjin) Co., Ltd.